Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery?

Area of Science:

• Cardiology
• Cardiac Surgery
• Medical Devices

Background:

• Paravalvular leaks after mitral valve replacement (MVR) often require surgical intervention, particularly in severely symptomatic individuals or those with persistent hemolysis.
• The long-term prognosis for patients with less severe symptoms or without transfusion-dependent hemolysis remains unclear.

Purpose of the Study:

• To evaluate the long-term outcomes of surgical versus conservative management for mitral paravalvular leaks (PVL) after MVR.
• To determine if surgical intervention benefits patients with milder symptoms or those not requiring blood transfusions.

Main Methods:

• A cohort of 96 patients with mitral PVL post-MVR was observed between 1987 and 1997.
• Patients were followed for an average of 5 years, with 50 undergoing surgical closure and 46 receiving conservative treatment.
• Outcomes including mortality, hematocrit levels, and New York Heart Association (NYHA) functional class were compared between groups.

Main Results:

• Patients undergoing surgery had lower preoperative hematocrit and a higher proportion of NYHA class III/IV symptoms.
• The 30-day postoperative mortality for reoperation was 6%, with an overall mortality of 12% in the surgical group versus 26% in the conservative group.
• Actuarial survival at 1, 5, and 10 years was significantly higher in the surgical group (98%, 90%, 88%) compared to the conservative group (90%, 75%, 68%).
• Surgery led to significant improvements in hematocrit levels, NYHA class, vertigo, and fatigue.

Conclusions:

• More aggressive surgical treatment for mitral paravalvular leaks is recommended.
• Surgery should be considered for less symptomatic patients and those not requiring blood transfusions.
• Early surgical intervention improves long-term survival and quality of life.